Synthetic glycopolypeptides as potential inhibitory agents for dendritic cells and HIV-1 trafficking

20Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Multivalent binding is a key for many critical biological processes and unique recognition and specificity in binding enables many of different glycans and proteins to work in a great harmony within the human body. In this study, the binding kinetics of synthetic glycopolypeptides to the dendritic cell lectin DC-SIGN and their inhibition potential for DC-SIGN interactions with the gp120 envelope glycoprotein of HIV-1 (gp120) are investigated. Synthetic glycopolymers and glycopolypeptides interact with lectins, which have a major role in biology. Here, the binding properties of glycopolypeptides and dendritic cell lectin, DC-SIGN, are investigated. Moreover, these structures effectively inhibit the binding between HIV glycoprotein, gp120, and DC-SIGN based on a detailed surface plasmon resonance study. © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Cite

CITATION STYLE

APA

Huang, J., Zhang, Q., Li, G. Z., Haddleton, D. M., Wallis, R., Mitchell, D., … Remzi Becer, C. (2013). Synthetic glycopolypeptides as potential inhibitory agents for dendritic cells and HIV-1 trafficking. Macromolecular Rapid Communications, 34(19), 1542–1546. https://doi.org/10.1002/marc.201300439

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free